Ken Warrington

Ken Warrington

Director/Miembro de la Junta en BIOSTEM TECHNOLOGIES, INC. .

Fortuna: 22 361 $ al 30/06/2026

Consumer Services
Health Technology

Perfil

Ken Warrington is currently Director at BioStem Technologies, Inc. since 2022, with employment at the company starting in 2019.
Former roles include Chief Technology Officer at Lacerta Therapeutics, Inc. from 2017 to 2019, Head-Strategy & Innovations at Genscript Probio Usa, Inc. from 2020 to 2021, and Senior VP-Operations & Business Development at Biostem Life Sciences, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Florida conferred in 2000 and an undergraduate degree from The St. Lawrence College conferred in 1993.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
30/09/2025 6.776 ( 0,04 % ) 22 361 $ 30/06/2026

Cargos activos de Ken Warrington

EmpresasCargoInicio
BIOSTEM TECHNOLOGIES, INC. Director/Miembro de la Junta 01/03/2022

Antiguos cargos conocidos de Ken Warrington.

EmpresasCargoFin
Corporate Officer/Principal 01/12/2021
Biostem Life Sciences, Inc.
Director de Operaciones 01/05/2020
Director Técnico/Científico/I+D 01/05/2019
Ver el detalle de la experiencia de Ken Warrington.

Formación de Ken Warrington.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

84

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Consumer Services

Health Technology

Consumer Services

Health Technology

Biostem Life Sciences, Inc.